Back

Influence of standard modifiable risk factors on ventricular tachycardia after myocardial infarction

27 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification, devices, and ablation in the management of malignant ventricular arrhythmias Invasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tejas Deshmukh

University of Sydney, Sydney (Australia)

7 More presentations in this session

Presentation thumbnail
Catheter ablation for ventricular tachycardia after myocardial infarction: meta-analysis of randomised controlled trials
Doctor R. Reddy (Durham, US)
Abstract Slides Video
Presentation thumbnail
Surpoint algorithm for improved guidance of ablation for ventricular tachycardia (SURFIRE-VT): a propensity-matched study
Doctor D. Sanders (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Association of ventricular tachycardia morphology induced on electrophysiology study after myocardial infarction: long-term survival and ventricular tachyarrhythmia recurrence
Doctor J. Kovoor (Westmead, AU)
Abstract Slides Video
Presentation thumbnail
Sex-differences in ventricular tachyarrhythmia events in patients with implantable cardioverter defibrillator and prior ventricular tachyarrhythmias
Doctor B. Krzowski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Neurohormonal status is associated with long-term appropriate implantable cardioverter defibrillator therapy for life-threatening ventricular arrhythmia
Professor F. Beygui (Caen, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification, devices, and ablation in the management of malignant ventricular arrhythmias

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: findings from the FRENCHIE cohort.
thumbnail
Congress Presentation
Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction
thumbnail
Congress Presentation
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources